• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞上的CD47表达是1型免疫反应的一种自我控制负调节因子。

CD47 expression on T cell is a self-control negative regulator of type 1 immune response.

作者信息

Bouguermouh Salim, Van Vu Quang, Martel Julie, Gautier Patrick, Rubio Manuel, Sarfati Marika

机构信息

Immunoregulation, Centre Hospitalier de l'Université de Montréal, Research Center, Hospital Notre-Dame, Montréal, Quebec, Canada.

出版信息

J Immunol. 2008 Jun 15;180(12):8073-82. doi: 10.4049/jimmunol.180.12.8073.

DOI:10.4049/jimmunol.180.12.8073
PMID:18523271
Abstract

The cytokine milieu and dendritic cells (DCs) direct Th1 development. Yet, the control of Th1 polarization by T cell surface molecules remains ill-defined. We here report that CD47 expression on T cells serves as a self-control mechanism to negatively regulate type 1 cellular and humoral immune responses in vivo. Th2-prone BALB/c mice that lack CD47 (CD47(-/-)) displayed a Th1-biased Ab profile at steady state and after immunization with soluble Ag. CD47(-/-) mice mounted a T cell-mediated exacerbated and sustained contact hypersensitivity (CHS) response. After their adoptive transfer to naive CD47-deficient hosts 1 day before immunization with soluble Ag, CD47(-/-) as compared with CD47(+/+)CD4(+) transgenic (Tg) T cells promoted the deviation of Ag-specific T cell responses toward Th1 that were characterized by a high IFN-gamma:IL-4 cytokine ratio. Although selective CD47 deficiency on DCs led to increased IL-12p70 production, CD47(-/-)Tg T cells produced more IFN-gamma and displayed higher T-bet expression than CD47(+/+) Tg T cells in response to OVA-loaded CD47(-/-) DCs. CD47 as part of the host environment has no major contribution to the Th1 polarization responses. We thus identify the CD47 molecule as a T cell-negative regulator of type 1 responses that may limit unwanted collateral damage to maximize protection and minimize host injury.

摘要

细胞因子环境和树突状细胞(DCs)指导Th1细胞的发育。然而,T细胞表面分子对Th1极化的控制仍不清楚。我们在此报告,T细胞上的CD47表达作为一种自我控制机制,在体内对1型细胞免疫和体液免疫反应起负调节作用。缺乏CD47(CD47-/-)的易发生Th2反应的BALB/c小鼠在稳态和用可溶性抗原免疫后呈现出偏向Th1的抗体谱。CD47-/-小鼠引发了T细胞介导的加剧且持续的接触性超敏反应(CHS)。在用可溶性抗原免疫前1天将其过继转移至缺乏CD47的幼稚宿主后,与CD47(+/+)CD4+转基因(Tg)T细胞相比,CD47-/- T细胞促进了抗原特异性T细胞反应向Th1的偏移,其特征是IFN-γ:IL-4细胞因子比值较高。尽管DCs上的选择性CD47缺陷导致IL-12p70产生增加,但在对负载OVA的CD47-/- DCs的反应中,CD47-/- Tg T细胞比CD47(+/+)Tg T细胞产生更多的IFN-γ并表现出更高的T-bet表达。作为宿主环境一部分的CD47对Th1极化反应没有主要贡献相关。因此,我们确定CD47分子是1型反应的T细胞负调节因子,它可能限制不必要的附带损害,以最大限度地提高保护并最小化宿主损伤。

相似文献

1
CD47 expression on T cell is a self-control negative regulator of type 1 immune response.T细胞上的CD47表达是1型免疫反应的一种自我控制负调节因子。
J Immunol. 2008 Jun 15;180(12):8073-82. doi: 10.4049/jimmunol.180.12.8073.
2
IL-6 production by pulmonary dendritic cells impedes Th1 immune responses.肺部树突状细胞产生的白细胞介素-6会阻碍Th1免疫反应。
J Immunol. 2003 May 1;170(9):4457-64. doi: 10.4049/jimmunol.170.9.4457.
3
Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.CD4+ T细胞发育从调节性辅助T细胞转向效应性辅助T细胞会改变接触性超敏反应。
Eur J Immunol. 1996 Nov;26(11):2606-12. doi: 10.1002/eji.1830261111.
4
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production.信号转导和转录激活因子3(STAT3)对于白细胞介素-27(IL-27)介导的细胞增殖不可或缺,但对于IL-27诱导的辅助性T细胞1(Th1)分化及促炎细胞因子产生的抑制并非必需。
J Immunol. 2008 Mar 1;180(5):2903-11. doi: 10.4049/jimmunol.180.5.2903.
5
Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.OX40共刺激增强树突状细胞在体内诱导的T细胞反应的发展。
J Immunol. 2002 Jan 15;168(2):661-70. doi: 10.4049/jimmunol.168.2.661.
6
Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.在转基因小鼠中强制表达GATA-3可抑制Th1分化,并在体内诱导形成表达T1/ST2的Th2定向T细胞区室。
J Immunol. 2001 Jul 15;167(2):724-32. doi: 10.4049/jimmunol.167.2.724.
7
N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells.N-乙酰葡糖胺基转移酶V(Mgat5)介导的N-糖基化负向调节T细胞产生Th1细胞因子。
J Immunol. 2004 Dec 15;173(12):7200-8. doi: 10.4049/jimmunol.173.12.7200.
8
Interaction of Ets-1 with HDAC1 represses IL-10 expression in Th1 cells.Ets-1 与 HDAC1 的相互作用抑制 Th1 细胞中 IL-10 的表达。
J Immunol. 2012 Mar 1;188(5):2244-53. doi: 10.4049/jimmunol.1101614. Epub 2012 Jan 20.
9
Self-limitation of Th1-mediated inflammation by IFN-gamma.干扰素-γ对Th1介导的炎症的自我限制作用。
J Immunol. 2006 Mar 1;176(5):2857-63. doi: 10.4049/jimmunol.176.5.2857.
10
CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors.
J Immunol. 2000 Oct 15;165(8):4624-31. doi: 10.4049/jimmunol.165.8.4624.

引用本文的文献

1
Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccine.针对重组带状疱疹疫苗的表位特异性记忆CD4+ T细胞反应的纵向单细胞分析
Nat Commun. 2025 Mar 8;16(1):2332. doi: 10.1038/s41467-025-57562-7.
2
Deciphering the role of CD47 in cancer immunotherapy.解析 CD47 在癌症免疫疗法中的作用。
J Adv Res. 2024 Sep;63:129-158. doi: 10.1016/j.jare.2023.10.009. Epub 2023 Oct 28.
3
Pan-cancer mapping of single CD8 T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity.
单细胞CD8 T细胞图谱的泛癌图谱揭示了一个调节CD28共刺激和抗肿瘤免疫的TCF1:CXCR6轴。
Cell Rep Med. 2024 Jul 16;5(7):101640. doi: 10.1016/j.xcrm.2024.101640. Epub 2024 Jul 2.
4
Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells.CD47-SIRPα信号通路的破坏可恢复肿瘤相关髓源性抑制细胞的炎症功能。
iScience. 2024 Mar 20;27(4):109546. doi: 10.1016/j.isci.2024.109546. eCollection 2024 Apr 19.
5
The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions.抗 CD47 抗体的抗肿瘤活性需要 Fc-FcγR 相互作用。
Cancer Cell. 2023 Dec 11;41(12):2051-2065.e6. doi: 10.1016/j.ccell.2023.10.007. Epub 2023 Nov 16.
6
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions.抗CD47抗体的抗肿瘤活性需要Fc-FcγR相互作用。
bioRxiv. 2023 Jun 29:2023.06.29.547082. doi: 10.1101/2023.06.29.547082.
7
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives.基于癌症中CD47疗法的核心:联合策略、机制及未来展望
Acta Pharm Sin B. 2023 Apr;13(4):1467-1487. doi: 10.1016/j.apsb.2022.12.016. Epub 2022 Dec 26.
8
CD47 restricts antiviral function of alveolar macrophages during influenza virus infection.CD47在流感病毒感染期间限制肺泡巨噬细胞的抗病毒功能。
iScience. 2022 Nov 11;25(12):105540. doi: 10.1016/j.isci.2022.105540. eCollection 2022 Dec 22.
9
Inflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8 T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation.炎症细胞因子增强幼稚 CD8 T 淋巴细胞对抗原的反应性,调节抗原刺激影响的基因的染色质可及性。
Int J Mol Sci. 2022 Nov 16;23(22):14122. doi: 10.3390/ijms232214122.
10
CD47 as a promising therapeutic target in oncology.CD47 作为肿瘤学中有前途的治疗靶点。
Front Immunol. 2022 Aug 22;13:757480. doi: 10.3389/fimmu.2022.757480. eCollection 2022.